An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s safety and immunogenicity...

By NewsDesk  @infectiousdiseasenews South Carolina health officials announced today the detection of two cases associated with the SARS-CoV-2 variant that first emerged recently in South Africa. These...

Biotechnology company,  Moderna Inc., today announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging...